We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Long-Awaited Guidance on CMO Quality Accords
FDA Issues Long-Awaited Guidance on CMO Quality Accords
July 1, 2013
The FDA has issued long-awaited guidance on how drugmakers and their contract manufacturing partners can best use quality agreements to ensure safe and effective drugs.